| Year |
Citation |
Score |
| 2020 |
Roberts ET, Glynn A, Donohue JM, Sabik LM. The Relationship Between Take-up of Prescription Drug Subsidies and Medicaid Among Low-Income Medicare Beneficiaries. Journal of General Internal Medicine. PMID 32959349 DOI: 10.1007/S11606-020-06241-Y |
0.354 |
|
| 2020 |
Germack HD, Drake C, Donohue JM, Golberstein E, Busch SH. National Trends in Outpatient Mental Health Service Use Among Adults Between 2008 and 2015. Psychiatric Services (Washington, D.C.). appips201900576. PMID 32907475 DOI: 10.1176/Appi.Ps.201900576 |
0.327 |
|
| 2020 |
Gu C, Huskamp H, Donohue J, Normand S. A Bayesian hierarchical model for characterizing the diffusion of new antipsychotic drugs. Biometrics. PMID 32627176 DOI: 10.1111/Biom.13324 |
0.393 |
|
| 2020 |
Hernandez I, Hershey TB, Donohue JM. Drug Shortages in the United States: Are Some Prices Too Low? Jama. 323: 819-820. PMID 32125409 DOI: 10.1001/Jama.2019.20504 |
0.314 |
|
| 2019 |
Hollander MAG, Donohue JM, Stein BD, Krans EE, Jarlenski MP. Association between Opioid Prescribing in Medicare and Pharmaceutical Company Gifts by Physician Specialty. Journal of General Internal Medicine. PMID 31792860 DOI: 10.1007/S11606-019-05470-0 |
0.32 |
|
| 2019 |
Metes ID, Xue L, Chang CH, Huskamp HA, Gellad WF, Lo-Ciganic WH, Choudhry NK, Richards-Shubik S, Guclu H, Donohue JM. Association between physician adoption of a new oral anti-diabetic medication and Medicare and Medicaid drug spending. Bmc Health Services Research. 19: 703. PMID 31619229 DOI: 10.1186/S12913-019-4520-4 |
0.374 |
|
| 2019 |
Cochran G, Cole ES, Warwick J, Donohue JM, Gordon AJ, Gellad WF, Bear T, Kelley D, DiDomenico E, Pringle J. Rural access to MAT in Pennsylvania (RAMP): a hybrid implementation study protocol for medication assisted treatment adoption among rural primary care providers. Addiction Science & Clinical Practice. 14: 25. PMID 31366408 DOI: 10.1186/S13722-019-0154-4 |
0.343 |
|
| 2019 |
Roberts ET, Hayley Welsh J, Donohue JM, Sabik LM. Association Of State Policies With Medicaid Disenrollment Among Low-Income Medicare Beneficiaries. Health Affairs (Project Hope). 38: 1153-1162. PMID 31260363 DOI: 10.1377/Hlthaff.2018.05165 |
0.314 |
|
| 2019 |
Radomski TR, Zhao X, Hanlon JT, Thorpe JM, Thorpe CT, Naples JG, Sileanu FE, Cashy JP, Hale JA, Mor MK, Hausmann LRM, Donohue JM, Suda KJ, Stroupe KT, Good CB, et al. Use of a medication-based risk adjustment index to predict mortality among veterans dually-enrolled in VA and medicare. Healthcare (Amsterdam, Netherlands). PMID 31031120 DOI: 10.1016/J.Hjdsi.2019.04.003 |
0.308 |
|
| 2019 |
Cole ES, DiDomenico E, Cochran G, Gordon AJ, Gellad WF, Pringle J, Warwick J, Chang CH, Kim JY, Kmiec J, Kelley D, Donohue JM. The Role of Primary Care in Improving Access to Medication-Assisted Treatment for Rural Medicaid Enrollees with Opioid Use Disorder. Journal of General Internal Medicine. PMID 30887440 DOI: 10.1007/S11606-019-04943-6 |
0.364 |
|
| 2019 |
Moyo P, Zhao X, Thorpe CT, Thorpe JM, Sileanu FE, Cashy JP, Hale JA, Mor MK, Radomski TR, Donohue JM, Hausmann LRM, Hanlon JT, Good CB, Fine MJ, Gellad WF. Dual Receipt of Prescription Opioids From the Department of Veterans Affairs and Medicare Part D and Prescription Opioid Overdose Death Among Veterans: A Nested Case-Control Study. Annals of Internal Medicine. PMID 30856660 DOI: 10.7326/M18-2574 |
0.342 |
|
| 2019 |
Hollander MAG, Jarlenski MP, Donohue JM, Cole ES, Kelley D, Krans EE. Medical Specialty of Buprenorphine Prescribers for Pregnant Women with Opioid Use Disorder. American Journal of Obstetrics and Gynecology. PMID 30703340 DOI: 10.1016/J.Ajog.2019.01.226 |
0.317 |
|
| 2019 |
Xue L, Boudreau RM, Donohue JM, Zgibor JC, Marcum ZA, Costacou T, Newman AB, Strotmeyer E. MULTIPLE MEDICATION USE AND RISK OF TREATED FALL INJURY: THE HEALTH ABC STUDY Innovation in Aging. 3: S19-S19. DOI: 10.1093/Geroni/Igz038.069 |
0.327 |
|
| 2018 |
Carico R, Zhao X, Thorpe CT, Thorpe JM, Sileanu FE, Cashy JP, Hale JA, Mor MK, Radomski TR, Hausmann LRM, Donohue JM, Suda KJ, Stroupe K, Hanlon JT, Good CB, et al. Receipt of Overlapping Opioid and Benzodiazepine Prescriptions Among Veterans Dually Enrolled in Medicare Part D and the Department of Veterans Affairs: A Cross-sectional Study. Annals of Internal Medicine. PMID 30304353 DOI: 10.7326/M18-0852 |
0.344 |
|
| 2018 |
Donohue JM, Guclu H, Gellad WF, Chang CH, Huskamp HA, Choudhry NK, Zhang R, Lo-Ciganic WH, Junker SP, Anderson T, Richards-Shubik S. Influence of peer networks on physician adoption of new drugs. Plos One. 13: e0204826. PMID 30273368 DOI: 10.1371/Journal.Pone.0204826 |
0.336 |
|
| 2018 |
Gopalan K, Lennon MH, Stein BD, Ghinassi F, Castle N, Chang J, Donohue J. Is Mental Illness a Risk Factor for Hospital Readmission? Administration and Policy in Mental Health. PMID 29796933 DOI: 10.1007/S10488-018-0874-X |
0.32 |
|
| 2018 |
Donohue JM, Huskamp HA. Doughnuts and Discounts - Changes to Medicare Part D under the Bipartisan Budget Act of 2018. The New England Journal of Medicine. 378: 1957-1960. PMID 29791823 DOI: 10.1056/Nejmp1802159 |
0.329 |
|
| 2017 |
Donohue JM, Barry CL, Stuart EA, Greenfield SF, Song Z, Chernew ME, Huskamp HA. Effects of Global Payment and Accountable Care on Medication Treatment for Alcohol and Opioid Use Disorders. Journal of Addiction Medicine. PMID 29189295 DOI: 10.1097/Adm.0000000000000368 |
0.353 |
|
| 2017 |
Anderson TS, Lo-Ciganic WH, Gellad WF, Zhang R, Huskamp HA, Choudhry NK, Chang CH, Richards-Shubik S, Guclu H, Jones B, Donohue JM. Patterns and predictors of physician adoption of new cardiovascular drugs. Healthcare (Amsterdam, Netherlands). PMID 29066168 DOI: 10.1016/J.Hjdsi.2017.09.004 |
0.356 |
|
| 2017 |
Frazier W, Cochran G, Lo-Ciganic WH, Gellad WF, Gordon AJ, Chang CH, Donohue JM. Medication-Assisted Treatment and Opioid Use Before and After Overdose in Pennsylvania Medicaid. Jama. 318: 750-752. PMID 28829862 DOI: 10.1001/Jama.2017.7818 |
0.355 |
|
| 2017 |
Donohue JM, Angus DC. National Shortages of Generic Sterile Injectable Drugs: Norepinephrine as a Case Study of Potential Harm. Jama. PMID 28322412 DOI: 10.1001/Jama.2017.2826 |
0.387 |
|
| 2017 |
Hanlon JT, Perera S, Newman AB, Thorpe JM, Donohue JM, Simonsick EM, Shorr RI, Bauer DC, Marcum ZA. Potential drug-drug and drug-disease interactions in well-functioning community-dwelling older adults. Journal of Clinical Pharmacy and Therapeutics. PMID 28111765 DOI: 10.1111/Jcpt.12502 |
0.341 |
|
| 2016 |
Cochran G, Gordon AJ, Lo-Ciganic WH, Gellad WF, Frazier W, Lobo C, Chang CH, Zheng P, Donohue JM. An Examination of Claims-based Predictors of Overdose from a Large Medicaid Program. Medical Care. PMID 27984346 DOI: 10.1097/Mlr.0000000000000676 |
0.333 |
|
| 2016 |
Stuart EA, Barry CL, Donohue JM, Greenfield SF, Duckworth K, Song Z, Kouri EM, Ebnesajjad C, Mechanic R, Chernew ME, Huskamp HA. Effects of Accountable Care and Payment Reform on Substance Use Disorder Treatment: Evidence from the Initial Three Years of the Alternative Quality Contract. Addiction (Abingdon, England). PMID 27517740 DOI: 10.1111/Add.13555 |
0.306 |
|
| 2016 |
Marcum ZA, Bellon JE, Li J, Gellad WF, Donohue JM. New chronic disease medication prescribing by nurse practitioners, physician assistants, and primary care physicians: a cohort study. Bmc Health Services Research. 16: 312. PMID 27464570 DOI: 10.1186/S12913-016-1569-1 |
0.311 |
|
| 2016 |
Lo-Ciganic WH, Donohue JM, Jones BL, Perera S, Thorpe JM, Thorpe CT, Marcum ZA, Gellad WF. Trajectories of Diabetes Medication Adherence and Hospitalization Risk: A Retrospective Cohort Study in a Large State Medicaid Program. Journal of General Internal Medicine. PMID 27229000 DOI: 10.1007/S11606-016-3747-6 |
0.306 |
|
| 2015 |
Lo-Ciganic WH, Gellad WF, Gordon AJ, Cochran G, Zemaitis MA, Cathers T, Kelley D, Donohue JM. Associations between trajectories of buprenorphine treatment and emergency department and inpatient utilization. Addiction (Abingdon, England). PMID 26662858 DOI: 10.1111/Add.13270 |
0.309 |
|
| 2015 |
Gordon AJ, Lo-Ciganic WH, Cochran G, Gellad WF, Cathers T, Kelley D, Donohue JM. Patterns and Quality of Buprenorphine Opioid Agonist Treatment in a Large Medicaid Program. Journal of Addiction Medicine. 9: 470-7. PMID 26517324 DOI: 10.1097/Adm.0000000000000164 |
0.409 |
|
| 2015 |
Lo-Ciganic WH, Donohue JM, Thorpe JM, Perera S, Thorpe CT, Marcum ZA, Gellad WF. Using machine learning to examine medication adherence thresholds and risk of hospitalization. Medical Care. 53: 720-8. PMID 26147866 DOI: 10.1097/Mlr.0000000000000394 |
0.316 |
|
| 2015 |
Donohue JM, Papademetriou E, Henderson RR, Frazee SG, Eibner C, Mulcahy AW, Mehrotra A, Bharill S, Cui C, Stein BD, Gellad WF. Early Marketplace Enrollees Were Older And Used More Medication Than Later Enrollees; Marketplaces Pooled Risk. Health Affairs (Project Hope). 34: 1049-56. PMID 26019223 DOI: 10.1377/Hlthaff.2015.0016 |
0.403 |
|
| 2015 |
Anderson TS, Huskamp HA, Epstein AJ, Barry CL, Men A, Berndt ER, Horvitz-Lennon M, Normand SL, Donohue JM. Antipsychotic prescribing: do conflict of interest policies make a difference? Medical Care. 53: 338-45. PMID 25769055 DOI: 10.1097/Mlr.0000000000000329 |
0.364 |
|
| 2015 |
Cochran G, Woo B, Lo-Ciganic WH, Gordon AJ, Donohue JM, Gellad WF. Defining Nonmedical Use of Prescription Opioids Within Health Care Claims: A Systematic Review. Substance Abuse. 36: 192-202. PMID 25671499 DOI: 10.1080/08897077.2014.993491 |
0.31 |
|
| 2015 |
Bao Y, Tang Y, Donohue J. Retaining Part D's comprehensive coverage of antidepressants: not a silver bullet. Jama Psychiatry. 72: 201-2. PMID 25607993 DOI: 10.1001/Jamapsychiatry.2014.2186 |
0.391 |
|
| 2015 |
Marcum ZA, Driessen J, Thorpe CT, Donohue JM, Gellad WF. Regional variation in use of a new class of antidiabetic medication among medicare beneficiaries: the case of incretin mimetics. The Annals of Pharmacotherapy. 49: 285-92. PMID 25515869 DOI: 10.1177/1060028014563951 |
0.312 |
|
| 2014 |
Donohue JM. The impact and evolution of Medicare Part D. The New England Journal of Medicine. 371: 693-5. PMID 25140954 DOI: 10.1056/Nejmp1402471 |
0.365 |
|
| 2014 |
Tang Y, Gellad WF, Men A, Donohue JM. Impact of medicare part D plan features on use of generic drugs. Medical Care. 52: 541-8. PMID 24824538 DOI: 10.1097/Mlr.0000000000000142 |
0.39 |
|
| 2014 |
Marcum ZA, Driessen J, Thorpe CT, Gellad WF, Donohue JM. Effect of multiple pharmacy use on medication adherence and drug-drug interactions in older adults with Medicare Part D. Journal of the American Geriatrics Society. 62: 244-52. PMID 24521363 DOI: 10.1111/Jgs.12645 |
0.396 |
|
| 2014 |
Donohue J, O'Malley AJ, Horvitz-Lennon M, Taub AL, Berndt ER, Huskamp HA. Changes in physician antipsychotic prescribing preferences, 2002-2007. Psychiatric Services (Washington, D.C.). 65: 315-22. PMID 24337224 DOI: 10.1176/Appi.Ps.201200536 |
0.339 |
|
| 2014 |
Gallini A, Andrieu S, Donohue JM, Oumouhou N, Lapeyre-Mestre M, Gardette V. Trends in use of antipsychotics in elderly patients with dementia: Impact of national safety warnings. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 24: 95-104. PMID 24126116 DOI: 10.1016/J.Euroneuro.2013.09.003 |
0.334 |
|
| 2013 |
Lo-Ciganic WH, Boudreau RM, Gray SL, Zgibor JC, Donohue JM, Perera S, Newman AB, Simonsick EM, Bauer DC, Satterfield S, Hanlon JT. Changes in cholesterol-lowering medications use over a decade in community-dwelling older adults. The Annals of Pharmacotherapy. 47: 984-92. PMID 23780807 DOI: 10.1345/Aph.1S050 |
0.313 |
|
| 2013 |
Gellad WF, Donohue JM, Zhao X, Mor MK, Thorpe CT, Smith J, Good CB, Fine MJ, Morden NE. Brand-name prescription drug use among Veterans Affairs and Medicare Part D patients with diabetes: a national cohort comparison. Annals of Internal Medicine. 159: 105-14. PMID 23752663 DOI: 10.7326/0003-4819-159-2-201307160-00664 |
0.397 |
|
| 2013 |
Fowler NR, Chen YF, Thurton CA, Men A, Rodriguez EG, Donohue JM. The impact of Medicare prescription drug coverage on the use of antidementia drugs Bmc Geriatrics. 13. PMID 23621892 DOI: 10.1186/1471-2318-13-37 |
0.381 |
|
| 2013 |
Gallini A, Donohue JM, Huskamp HA. Diffusion of antipsychotics in the US And French markets, 1998-2008. Psychiatric Services (Washington, D.C.). 64: 680-7. PMID 23584568 DOI: 10.1176/Appi.Ps.004662012 |
0.307 |
|
| 2013 |
Kornfield R, Donohue J, Berndt ER, Alexander GC. Promotion of Prescription Drugs to Consumers and Providers, 2001-2010 Plos One. 8. PMID 23469165 DOI: 10.1371/Journal.Pone.0055504 |
0.317 |
|
| 2013 |
Marcum ZA, Zheng Y, Perera S, Strotmeyer E, Newman AB, Simonsick EM, Shorr RI, Bauer DC, Donohue JM, Hanlon JT. Prevalence and correlates of self-reported medication non-adherence among older adults with coronary heart disease, diabetes mellitus, and/or hypertension. Research in Social & Administrative Pharmacy : Rsap. 9: 817-27. PMID 23291338 DOI: 10.1016/J.Sapharm.2012.12.002 |
0.313 |
|
| 2013 |
Huskamp HA, O'Malley AJ, Horvitz-Lennon M, Taub AL, Berndt ER, Donohue JM. How quickly do physicians adopt new drugs? The case of second-generation antipsychotics. Psychiatric Services (Washington, D.C.). 64: 324-30. PMID 23280376 DOI: 10.1176/Appi.Ps.201200186 |
0.365 |
|
| 2013 |
Horvitz-Lennon M, Donohue JM, Lave JR, Alegría M, Normand SL. The effect of race-ethnicity on the comparative effectiveness of clozapine among Medicaid beneficiaries. Psychiatric Services (Washington, D.C.). 64: 230-7. PMID 23242347 DOI: 10.1176/Appi.Ps.201200041 |
0.312 |
|
| 2013 |
Tang Y, Gellad WF, Men A, Donohue JM. Regional Variation In Use Of Generic Drugs And Medicare Prescription Drug Cost Sharing Value in Health. 16. DOI: 10.1016/J.Jval.2013.03.1265 |
0.364 |
|
| 2012 |
Dusetzina SB, Busch AB, Conti RM, Donohue JM, Alexander GC, Huskamp HA. Changes in antipsychotic use among patients with severe mental illness after a Food and Drug Administration advisory. Pharmacoepidemiology and Drug Safety. 21: 1251-60. PMID 22553074 DOI: 10.1002/Pds.3272 |
0.335 |
|
| 2012 |
Gellad WF, Donohue JM, Zhao X, Zhang Y, Banthin JS. The financial burden from prescription drugs has declined recently for the nonelderly, although it is still high for many. Health Affairs (Project Hope). 31: 408-16. PMID 22323172 DOI: 10.1377/Hlthaff.2011.0469 |
0.414 |
|
| 2012 |
Donohue JM, Morden NE, Gellad WF, Bynum JP, Zhou W, Hanlon JT, Skinner J. Sources of regional variation in Medicare Part D drug spending. The New England Journal of Medicine. 366: 530-8. PMID 22316446 DOI: 10.1056/Nejmsa1104816 |
0.345 |
|
| 2011 |
Donohue JM, Zhang Y, Aiju M, Perera S, Lave JR, Hanlon JT, Reynolds CF. Impact of Medicare Part D on antidepressant treatment, medication choice, and adherence among older adults with depression. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 19: 989-97. PMID 22123272 DOI: 10.1097/Jgp.0B013E3182051A9B |
0.37 |
|
| 2011 |
Polinski JM, Donohue JM, Kilabuk E, Shrank WH. Medicare Part D's effect on the under- and overuse of medications: a systematic review. Journal of the American Geriatrics Society. 59: 1922-33. PMID 21806563 DOI: 10.1111/J.1532-5415.2011.03537.X |
0.406 |
|
| 2011 |
Gellad WF, Huskamp HA, Li A, Zhang Y, Safran DG, Donohue JM. Use of prescription drug samples and patient assistance programs, and the role of doctor-patient communication. Journal of General Internal Medicine. 26: 1458-64. PMID 21751052 DOI: 10.1007/S11606-011-1801-Y |
0.379 |
|
| 2011 |
Zhang Y, Donohue JM, Lave JR, Gellad WF. The impact of Medicare Part D on medication treatment of hypertension. Health Services Research. 46: 185-98. PMID 20880045 DOI: 10.1111/J.1475-6773.2010.01183.X |
0.406 |
|
| 2010 |
Zhang Y, Lee BY, Donohue JM. Ambulatory antibiotic use and prescription drug coverage in older adults. Archives of Internal Medicine. 170: 1308-14. PMID 20696953 DOI: 10.1001/Archinternmed.2010.235 |
0.359 |
|
| 2010 |
Donohue JM, Zhang Y, Lave JR, Gellad WF, Men A, Perera S, Hanlon JT. The Medicare drug benefit (Part D) and treatment of heart failure in older adults. American Heart Journal. 160: 159-65. PMID 20598987 DOI: 10.1016/J.Ahj.2010.04.023 |
0.353 |
|
| 2010 |
Zhang Y, Lave JR, Donohue JM, Fischer MA, Chernew ME, Newhouse JP. The impact of Medicare Part D on medication adherence among older adults enrolled in Medicare-Advantage products. Medical Care. 48: 409-17. PMID 20393360 DOI: 10.1097/Mlr.0B013E3181D68978 |
0.369 |
|
| 2010 |
Zhang Y, Lave JR, Newhouse JP, Donohue JM. How the Medicare Part D drug benefit changed the distribution of out-of-pocket pharmacy spending among older beneficiaries. The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences. 65: 502-7. PMID 20008482 DOI: 10.1093/Geronb/Gbp111 |
0.348 |
|
| 2009 |
Zhang Y, Donohue JM, Lave JR, O'Donnell G, Newhouse JP. The effect of Medicare Part D on drug and medical spending. The New England Journal of Medicine. 361: 52-61. PMID 19571283 DOI: 10.1056/Nejmsa0807998 |
0.414 |
|
| 2009 |
Donohue JM, Huskamp HA, Wilson IB, Weissman J. Whom do older adults trust most to provide information about prescription drugs? The American Journal of Geriatric Pharmacotherapy. 7: 105-16. PMID 19447363 DOI: 10.1016/J.Amjopharm.2009.04.005 |
0.384 |
|
| 2009 |
Donohue JM, Huskamp HA, Zuvekas SH. Dual eligibles with mental disorders and Medicare part D: how are they faring? Health Affairs (Project Hope). 28: 746-59. PMID 19414883 DOI: 10.1377/Hlthaff.28.3.746 |
0.332 |
|
| 2009 |
Zhang Y, Donohue JM, Newhouse JP, Lave JR. The effects of the coverage gap on drug spending: a closer look at Medicare Part D. Health Affairs (Project Hope). 28: w317-25. PMID 19189991 DOI: 10.1377/Hlthaff.28.2.W317 |
0.358 |
|
| 2008 |
Huskamp HA, Donohue JM, Koss C, Berndt ER, Frank RG. Generic entry, reformulations and promotion of SSRIs in the US. Pharmacoeconomics. 26: 603-16. PMID 18563951 DOI: 10.2165/00019053-200826070-00007 |
0.355 |
|
| 2008 |
Donohue JM, Fischer MA, Huskamp HA, Weissman JS. Potential savings from an evidence-based consumer-oriented public education campaign on prescription drugs. Health Services Research. 43: 1557-75. PMID 18479406 DOI: 10.1111/J.1475-6773.2008.00858.X |
0.338 |
|
| 2007 |
Donohue JM, Frank RG. Estimating Medicare Part D's impact on medication access among dually eligible beneficiaries with mental disorders. Psychiatric Services (Washington, D.C.). 58: 1285-91. PMID 17914004 DOI: 10.1176/Appi.Ps.58.10.1285 |
0.398 |
|
| 2007 |
Donohue JM, Cevasco M, Rosenthal MB. A decade of direct-to-consumer advertising of prescription drugs. The New England Journal of Medicine. 357: 673-81. PMID 17699817 DOI: 10.1056/Nejmsa070502 |
0.369 |
|
| 2007 |
Aspinall S, Sevick MA, Donohue J, Maher R, Hanlon JT. Medication errors in older adults: a review of recent publications. The American Journal of Geriatric Pharmacotherapy. 5: 75-84. PMID 17608250 DOI: 10.1016/J.Amjopharm.2007.03.009 |
0.388 |
|
| 2007 |
Huskamp HA, Stevenson DG, Donohue JM, Newhouse JP, Keating NL. Coverage and prior authorization of psychotropic drugs under Medicare Part D. Psychiatric Services (Washington, D.C.). 58: 308-10. PMID 17325102 DOI: 10.1176/Appi.Ps.58.3.308 |
0.351 |
|
| 2006 |
Donohue J. A History of Drug Advertising: The Evolving Roles of Consumers and Consumer Protection Milbank Quarterly. 84: 659-699. PMID 17096638 DOI: 10.1111/J.1468-0009.2006.00464.X |
0.381 |
|
| 2006 |
Donohue J. Mental Health In The Medicare Part D Drug Benefit: A New Regulatory Model? Health Affairs. 25: 707-719. PMID 16684735 DOI: 10.1377/Hlthaff.25.3.707 |
0.415 |
|
| 2006 |
Donohue JM. Direct-to-consumer advertising of prescription drugs: Does it add to the overuse and inappropriate use of prescription drugs or alleviate underuse? International Journal of Pharmaceutical Medicine. 20: 17-24. DOI: 10.2165/00124363-200620010-00002 |
0.417 |
|
| 2005 |
Donohue J, Hanlon JT. Helping Medicare patients benefit from the new Medicare drug benefit: an overview with practice tips. American Journal of Geriatric Cardiology. 14: 291-297. PMID 16276125 DOI: 10.1111/J.1076-7460.2005.04914.X |
0.41 |
|
| 2005 |
Donohue JM. Economic grand rounds: the economics of the new medicare drug benefit: implications for people with mental illnesses. Psychiatric Services (Washington, D.C.). 56: 645-7. PMID 15939937 DOI: 10.1176/Appi.Ps.56.6.645 |
0.309 |
|
| 2004 |
Donohue JM, Berndt ER, Rosenthal M, Epstein AM, Frank RG. Effects of pharmaceutical promotion on adherence to the treatment guidelines for depression. Medical Care. 42: 1176-85. PMID 15550797 DOI: 10.1097/00005650-200412000-00004 |
0.31 |
|
| 2004 |
Donohue JM, Berndt ER. Effects of direct-to-consumer advertising on medication choice: The case of antidepressants Journal of Public Policy and Marketing. 23: 115-127. DOI: 10.1509/Jppm.23.2.115.51395 |
0.327 |
|
| 2003 |
Rosenthal MB, Berndt ER, Donohue JM, Epstein AM, Frank RG. Demand Effects of Recent Changes in Prescription Drug Promotion Forum For Health Economics & Policy. 6: 1-26. DOI: 10.2202/1558-9544.1044 |
0.35 |
|
| 2002 |
Rosenthal MB, Berndt ER, Donohue JM, Frank RG, Epstein AM. Promotion of prescription drugs to consumers. The New England Journal of Medicine. 346: 498-505. PMID 11844852 DOI: 10.1056/Nejmsa012075 |
0.391 |
|
| Show low-probability matches. |